|
 |
| home > pmps > winter 2003 > the countdown starts for implementing new child-resistant/senior-friendly blister packaging |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
In August 2003, the Medicines & Healthcare Products Regulatory Agency (MHRA) announced that the Government had accepted its recommendations for the introduction of greater safety measures on certain non-reclosable blister-packed drugs. These recommendations were put forward following the tragic death of a toddler after he accidentally overdosed on iron tablets contained in a standard blister pack.
Following this, on the 1st October 2003 a new legal standard for drugs packaging came into force. This new legislation marked the first step in moving the pharmaceutical industry towards delivering safer versions of non-reclosable blister-packed drugs. The legislation introduces a child-resistance standard based on the BS8404 test, which requires blister packs to be both child-resistant and senior-friendly, ensuring that the addition of barriers for children do not prevent the elderly from accessing capsules. This new standard has now been introduced for paracetamol, aspirin and iron tablets (containing more than 24mg of iron per tablet).
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EMBALLAGE 2008. World Packaging Exhibition
16-21 November 2008, Paris-Nord Villepinte - France
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
